Save information for later
Sign Up

Learn About Pseudomyxoma Peritonei

What is the definition of Pseudomyxoma Peritonei?
Pseudomyxoma peritonei (PMP) is a rare disease characterized by the presence of mucin in the abdominal (peritoneal) cavity. While the most common cause of PMP is appendix cancer, several types of tumors (including non-cancerous tumors) can cause PMP. Signs and symptoms may include an increase in abdominal size or bloating; inguinal hernia (in men); an ovarian mass that may be felt during a routine pelvic exam (in women); pain or discomfort in the abdomen; and/or appendicitis.
What are the alternative names for Pseudomyxoma Peritonei?
  • Pseudomyxoma peritonei
  • Adenomucinosis
  • Gelatinous ascites
  • PMP
  • Syndrome of pseudomyxoma peritonei
Who are the top Pseudomyxoma Peritonei Local Doctors?
Experienced in Pseudomyxoma Peritonei
Experienced in Pseudomyxoma Peritonei

Schuylkill Health System Medical Group, Inc.

205 E Laurel Blvd, 
Pottsville, PA 
 (17.4 mi)
Languages Spoken:
English

Carol Miller-Schaeffer is an Internal Medicine provider in Pottsville, Pennsylvania. Dr. Miller-Schaeffer and is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Necrosis, Lung Metastases, Rhabdomyolysis, and Type 2 Diabetes (T2D).

Experienced in Pseudomyxoma Peritonei
Hematology Oncology | Hematology | Oncology
Experienced in Pseudomyxoma Peritonei
Hematology Oncology | Hematology | Oncology

Hazleton Professional Services

384 Airport Rd, 
Hazle Township, PA 
 (9.5 mi)
Languages Spoken:
English

Michael Evans is a Hematologist Oncology specialist and a Hematologist in Hazle Township, Pennsylvania. Dr. Evans and is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Small Cell Lung Cancer (SCLC), and Multiple Myeloma.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Pseudomyxoma Peritonei
Hematology Oncology | Hematology | Oncology
Experienced in Pseudomyxoma Peritonei
Hematology Oncology | Hematology | Oncology

Lehigh Valley Physician Group

700 E Broad St, Lvpg Emergency Medicine, 
Hazelton, PA 
 (10.9 mi)
Languages Spoken:
English

Brian Patson is a Hematologist Oncology specialist and a Hematologist in Hazelton, Pennsylvania. Dr. Patson and is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration.

What are the latest Pseudomyxoma Peritonei Clinical Trials?
Fluorouracil-labeled Nascent RNA Technology for Evaluating the Effects of Different Hyperthermic Intraperitoneal Chemotherapy Regimens on the Transcriptome of Pseudomyxoma Peritonei

Summary: The main objective of this study is to combine HIPEC regimens with Flura-seq to detect the effects of different HIPEC regimens (cisplatin vs. cisplatin+ docetaxel) on the nascent transcriptome of PMP tumors, so as to quantitatively assess the efficacy of different HIPEC regimens in the early stage, and to lay the foundation for optimizing the HIPEC regimens and exploring new therapeutic targets.

Match to trials
Find the right clinical trials for you in under a minute
Get started
GaStrointestinal STIMULation As a Treatment of Postoperative IlEus Following Extensive Surgery (STIMULATE). -A Prospective Double-blinded Randomized Controlled Trial

Summary: The goal of this clinical trial is to investigate the effect of gastrointestinal stimulation with a pacemaker on the length of postoperative bowel paralysis in patients undergoing major abdominal surgery due to metastasizing colorectal cancer, appendiceal cancer or pseudomyxoma peritonei. The main question it aims to answer is if the length of postoperative ileus is reduced when the gastrointestin...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Pseudomyxoma Peritonei?